Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)
Titel:
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)
Auteur:
Chekerov, Radoslav Arndt, Tjadina Pietzner, Klaus Canzler, Ulrich Wimberger, Pauline Strauß, Hans-Georg Mahner, Sven Woelber, Linn de Gregorio, Nikolaus Stocker, Gertraud von Abel, Ekkehard Neunhoeffer, Tanja Belau, Antje Kristina Mustea, Alexander Yalinkaya, Isil Braicu, Elena Ioana Richter, Rolf Sehouli, Jalid ,